Drug Testing - (0513) — MM 0513 | CIGNA Coverage Update

Cigna modified MM 0513, its drug testing coverage policy, effective September 26, 2025. Here's what billing teams need to know.

Cigna Healthcare updated Coverage Policy MM 0513 governing drug testing services — specifically presumptive testing under CPT codes 80305, 80306, and 80307, and definitive testing under HCPCS codes G0480, G0481, G0482, G0483, G0659, and P2031. The modification affects any practice or lab billing Cigna for substance use disorder monitoring, pain management drug testing, or addiction treatment support. If your revenue cycle touches these codes, review your charge capture and documentation workflows before September 26, 2025.

Quick-Reference Table

Cigna Drug Testing Coverage Criteria and Medical Necessity Requirements 2025

MM 0513 is Cigna Healthcare's coverage policy governing drug testing across two distinct test types: presumptive and definitive. Getting that distinction right in your documentation is what separates a paid claim from a denial.

Presumptive testing (CPT 80305, 80306, 80307) is qualitative. It tells you whether a drug or metabolite is detectable above a threshold concentration — present or absent. Think of it as a screening tool. The three CPT codes map to the method of reading the result: 80305 is self-read capability, 80306 is read by direct optical observation, and 80307 is read by instrument-assisted analysis.

Definitive testing (HCPCS G0480, G0481, G0482, G0483, G0659) is quantitative. It tells you how much of a drug or metabolite is present. That level of specificity is what clinical teams need when they're managing a patient's treatment plan for addiction — adjusting dosing, confirming compliance, or ruling out diversion. Each G code maps to a different number of drug classes analyzed, so the code you bill must match the actual panel performed.

Cigna designates all nine of these codes as medically necessary when clinical criteria are met. The coverage policy ties medical necessity to clinical context: the patient must be undergoing treatment for addiction or substance use disorder. This isn't a wellness benefit. Billing these codes for pre-employment screening or forensic testing won't meet medical necessity under MM 0513.

Hair analysis under HCPCS P2031 also appears in the policy, covered when criteria are met. Hair analysis is less common in clinical billing than urine-based testing, but it shows up in chronic pain and addiction monitoring contexts. Know it's there if your practice uses it.

Whether prior authorization applies depends on the specific Cigna plan. Commercial plans, Cigna-administered ASO accounts, and Exchange products can vary. Check prior authorization requirements plan-by-plan before scheduling definitive testing, especially for higher-tier HCPCS codes like G0483 and G0659, which represent larger panels and carry higher reimbursement — and more scrutiny.

Coverage Indications at a Glance

Cigna Drug Testing Exclusions and Non-Covered Indications

MM 0513 is built around a specific clinical purpose: diagnosing and monitoring patients in addiction treatment. That scope matters. The policy's medical necessity standard excludes testing ordered outside that therapeutic relationship.

Pre-employment drug screening doesn't qualify. Forensic testing ordered for legal proceedings doesn't qualify. School or workplace compliance panels don't qualify. If the testing isn't tied to an active addiction treatment episode, the clinical necessity basis doesn't hold under this coverage policy.

Watch out for panel mismatch on definitive testing. Billing G0483 (22+ drug classes) when the lab only analyzed 12 classes isn't a gray area — it's a coding error with claim denial and potential overpayment recovery risk. The lab report must support the HCPCS code billed. Make sure your charge capture pulls from the actual test result, not a standing order template.

Cigna Drug Testing Billing Guidelines and Action Items 2025

The effective date is September 26, 2025. That's your deadline. Here are the steps to take before then.

CPT, HCPCS, and ICD-10 Codes for Drug Testing Under MM 0513

Covered CPT Codes (When Medical Necessity Criteria Are Met)

Covered HCPCS Codes (When Medical Necessity Criteria Are Met)

Note on ICD-10 codes: MM 0513 as published does not specify a required ICD-10-CM code list. Medical necessity is established through clinical context and documentation, not a defined diagnosis code set. The most common supporting diagnoses in this context include substance use disorder codes in the F10–F19 range. Confirm with your compliance officer which diagnosis codes your documentation supports before submitting claims.